DiaMedica Therapeutics DMAC Earnings Call Transcripts

NASDAQ DMAC
$9.66 -0.01 (-0.10%)
At close: Nov 11, 2026 · 4:00 PM EST
3 earnings calls on file for DiaMedica Therapeutics, from Q4 2025 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

DiaMedica Therapeutics Q2 2026 Earnings Call

Aug 11, 2026 4,366 words · 19 min read
  • Dietrich PaulsPresident and Chief Executive Officer
  • Julie KropChief Medical Officer
  • Scott KellenChief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

DiaMedica Therapeutics Earnings Call Transcripts

Calls3
LatestAug 11, 2026
SinceQ4 2025

Fiscal 2026

Fiscal 2025

All 3 DiaMedica Therapeutics transcripts Register to get access to DiaMedica Therapeutics’s earnings call transcripts.